Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
CANbridge Pharmaceuticals (MF1.F) Q3 2025 Earnings
MF1.F
31
Aug
Confirmed
Q1 2024
Q3 2024
Q1 2025
Q3 2025
-0.07
-0.04
-0.01
0.02
Details
Expected EPS
N/A
Actual EPS
0.01671175443
Surprise EPS
0.02
Surprise Percent
+∞%
Description
CANbridge Pharmaceuticals (MF1.F) has reported earnings of 0.01671175443 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login